日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Association of Systolic and Diastolic Blood Pressure with the Risk of End-Stage Renal Disease in Older Type 2 Diabetes Mellitus Patients without Cardiovascular Disease: A Nationwide Population-Based Study (Diabetes Metab J 2025;49:1308-17)

收缩压和舒张压与老年 2 型糖尿病患者(无心血管疾病)终末期肾病风险的关联:一项全国性人群研究(Diabetes Metab J 2025;49:1308-17)

Hong, Sangmo; Han, Kyungdo; Park, Kye-Yeung; Lee, Chang Beom; Kim, Dong Sun; Park, Jung Hwan; Yu, Sung Hoon

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)

在韩国 2 型糖尿病合并血脂异常患者中,换用依折麦布 10 mg/瑞舒伐他汀 2.5 mg 的疗效和安全性:一项多中心前瞻性研究(EROICA 研究)

Hong, Sangmo; Kim, Won J; Kim, Sungrae; Park, Jung H; Kang, Eun S; Moon, Min K; Kim, Jae T; Mok, Ji-Oh; Lee, Ki Y; Park, Cheol-Young; Lee, Chang B

Circulating Branched-Chain Amino Acids are Associated with Higher Odds of Obesity: Findings from the FiLWHEL Study

循环支链氨基酸与更高的肥胖风险相关:来自 FiLWHEL 研究的发现

Okekunle, Akinkunmi Paul; Lee, Heejin; Provido, Sherlyn Mae P; Chung, Grace H; Hong, Sangmo; Yu, Sung Hoon; Lee, Chang Beom; Lee, Jung Eun

Diindolocarbazole as a Core Structure for Narrow-Emitting and Highly Efficient Blue Organic Light-Emitting Diodes

二吲哚咔唑作为窄发射高效蓝色有机发光二极管的核心结构

Kang, Jihoon; Moon, Junyoung; Jeon, Soon Ok; Jo, Unhyeok; Han, Seungwon; Kim, Sangmo; Lee, Jun Yeob

Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study

RAS抑制剂和SGLT2抑制剂单独或联合应用对合并糖尿病和高血压患者终末期肾病和/或全因死亡的影响:一项全国性队列研究

Hong, Sangmo; Han, Kyungdo; Kim, Kyung-Soo; Park, Cheol-Young

Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality

暂时性MASLD与2型糖尿病、心血管疾病和死亡率的关联

Han, Eugene; Han, Kyung-Do; Lee, Yong-Ho; Kim, Kyung-Soo; Hong, Sangmo; Park, Jung Hwan; Park, Cheol-Young

Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes

依那格列净(一种选择性SGLT2抑制剂)可改善2型糖尿病患者的脂肪因子谱,且该改善作用与体重无关。

Lyu, Young Sang; Lee, Hansol; Kim, Kyung-Soo; Hong, Sangmo; Park, Cheol-Young

Association of Systolic and Diastolic Blood Pressure with the Risk of End-Stage Renal Disease in Older Type 2 Diabetes Mellitus Patients without Cardiovascular Disease: A Nationwide Population-Based Study

收缩压和舒张压与老年2型糖尿病患者(无心血管疾病)终末期肾病风险的关联:一项全国性人群研究

Hong, Sangmo; Han, Kyungdo; Park, Kye-Yeung; Lee, Chang Beom; Kim, Dong Sun; Park, Jung Hwan; Yu, Sung Hoon

Evaluation of the efficacy and safety of controlled-release phentermine/topiramate in adults with obesity in Korea: A randomized, double-blind, placebo-controlled, phase 4 trial (QUEEN's study)

评估控释芬特明/托吡酯在韩国肥胖成人中的疗效和安全性:一项随机、双盲、安慰剂对照的 4 期试验(QUEEN 研究)

Hong, Sangmo; Kim, Won Jun; Kang, Eun Seok; Jeong, In-Kyung; Kim, Chong Hwa; Lee, Ki Young; Kim, Sungrae; Oh, Seung Joon; Lee, Chang Beom

Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]

纳曲酮-安非他酮治疗对超重患者的潜在心血管风险 [对来信的回应]

Lyu, Young Sang; Ahn, Hongyup; Hong, Sangmo; Park, Cheol-Young